Evidence map›Paper›PMID 32422947›Full record

ReviewInternational journal of molecular sciences2020

Nutrients and Porphyria: An Intriguing Crosstalk.

Elena Di Pierro, Francesca Granata

Open access · goldAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 34 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Preventing hyperhomocysteinemia using vitamin BMolecular genetics and metabolism reports · 2024
    Article
  5. Porphyrinuria in Autism Spectrum Disorder: A Review.Current medicinal chemistry · 2024
    Review
  6. Article
  7. Article
  8. Nutritional Interventions withInternational journal of molecular sciences · 2023
    Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Elena Di PierroFondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, UOC General Medicine, via F. Sforza 35, 20122 Milan, Italy.
Francesca GranataFondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, UOC General Medicine, via F. Sforza 35, 20122 Milan, Italy.ORCID 0000-0002-1115-3374
Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Porphyria refers to a group of fascinating diseases from a metabolic and nutritional standpoint as it provides an example of how metabolic manipulation can be used for therapeutic purposes. It is characterized by defects in heme synthesis, particularly in the erythrocytes and liver. Specific enzymes involved in heme biosynthesis directly depend on adequate levels of vitamins and minerals in the tissues. Moreover, micronutrients that are required for producing succinyl CoA and other intermediates in the Krebs (TCA) cycle are indirectly necessary for heme metabolism. This review summarizes articles that describe the nutritional status, supplements intake, and dietary practices of patients affected by porphyria, paying special attention to the therapeutic use of nutrients that may help or hinder this group of diseases.

Indexed as

Dietary SupplementsHumansMicronutrientsMineralsNutrientsNutritional StatusPorphyriasVitaminsMicronutrientsMineralsNutrientsVitaminsdietgenetic factorsiron metabolismlipid and glucose metabolismnutrientsnutrigenomicspersonalized nutritionporphyria

Identifiers

PMID32422947
PMCPMC7279006
OpenAlexW3024029987

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.